|
|
|
|
Nivolumab in Patients With Advanced Hepatocellular
Carcinoma: the CheckMate 040 Study
|
|
|
Reported by Jules Levin
AASLD 2016 Nov 11-15
Patrice Cacoub1,2, Mathieu Vautier 1,2, Anne Claire Desbois 1,2, Marianne Doz 3, Zobair Younossi 4,5
1APHP, La Pitie-Salpêtrière Hospital, Department of Internal Medicine and Clinical Immunology, 2.Universite Pierre et Marie Curie, Paris, France, 3.CEMKA, Paris, France, 4Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, United States. 5Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States
|
|
|
|
|
|
|